|
|
|
|
| LEADER |
04825nam a22005055i 4500 |
| 001 |
23684 |
| 003 |
DE-He213 |
| 005 |
20151204165244.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s1999 ne | s |||| 0|eng d |
| 020 |
# |
# |
|a 9780585379739
|9 978-0-585-37973-9
|
| 024 |
7 |
# |
|a 10.1007/978-0-585-37973-9
|2 doi
|
| 050 |
# |
4 |
|a RC681-688.2
|
| 072 |
# |
7 |
|a MJD
|2 bicssc
|
| 072 |
# |
7 |
|a MED010000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.12
|2 23
|
| 245 |
1 |
0 |
|a WomenỚ"s Health and Menopause
|h [electronic resource].
|
| 264 |
# |
1 |
|a Dordrecht :
|b Springer Netherlands,
|c 1999.
|
| 300 |
# |
# |
|a XXIII, 291 p.
|b online resource.
|
| 336 |
# |
# |
|a text
|b txt
|2 rdacontent
|
| 337 |
# |
# |
|a computer
|b c
|2 rdamedia
|
| 338 |
# |
# |
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
# |
# |
|a text file
|b PDF
|2 rda
|
| 490 |
1 |
# |
|a Medical Science Symposia Series, Risk Reduction Strategies Ớ Improved Quality of Health ;
|v 13
|
| 505 |
0 |
# |
|a An Aging Humankind: New Realities -- Menopause -- Does Menopause Increase the Risk of Coronary Heart Disease? -- Chronic Low-Grade Metabolic Acidosis in Normal Adult Humans: Pathophysiology and Consequences -- The Menopause, Sex Hormones, and Rheumatic Disease -- Estrogen-Progestrogen Action -- Novel Mechanisms of Estrogen Action -- The Action of Ovarian Steroid Hormones on Tissues and Organs -- Nongenomic Mechanisms of Sex Hormones -- Action of Specific Estrogens on Vascular Cells -- Direct Actions of Estrogen on Vascular Cells Ameliorates Response to Injury -- Newer Progestogens -- Cardiovascular Risk -- Cardiovascular Disease: Risk Factors Related to Thrombosis -- Estrogen Effect upon Coronary Vasculature -- Estrogen and Endothelial Function -- Action of Specific Estrogens on the Coronary Artery: Effects on Lipoproteins, Coagulation, and Fibrinolysis -- Coronary Heart Disease in Women: Status 1998 -- Osteoporosis -- to Osteoporosis -- Genetics of Osteoporosis -- The Clinical Management of Osteoporosis -- Central Nervous System -- Menopause and Psychopharmacology: Signs, Symptoms, and Treatment -- The Brain: Target and Source for Sex Steroid Hormones -- The Role of Estrogen in Brain Aging and AlzheimerỚ"s Disease -- Role of Estrogens in Dementing Illnesses: Hypotheses on the Biological Rationale -- Hormone Replacement Therapy -- WomenỚ"s Health and Menopause Epidemiology: The USA Experience -- Doses, Duration, and Starting Age for HRT Treatment: The American Viewpoint -- Estrogen Complexes Contained in Conjugated Equine Estrogens (CEE): An Overview of Their Structure and Possible Effects on Target Tissue -- Once a Week Transdermal EstrogenỚ Quality of Life Improvement in Long-Term Replacement Therapy: Newest Findings -- Estrogen-Androgen Hormone Replacement Therapy -- Management of the Late Menopause: Ultra Low-Dose Adjustive Estrogen Therapy -- Selective Estrogen Receptor Modulator (SERM) Drugs for the Prevention of Osteoporosis -- A Rationale for Hormone Replacement Therapy in Organ Transplant Patients -- Management of Ambivalence Towards Hormone Replacement Therapy -- Oncology -- Breast and Female Genital Tract Neoplasms in Overweight Women -- Postmenopausal Hormone Replacement Therapy and Gynecological Malignancies -- Hormone Replacement Therapy and Breast Cancer Risk in High-Risk Subgroups -- Breast Cancer and HRT: Collaborative Reanalysis of Data -- A Summary of the Evidence Relating Postmenopausal Hormone Use and Large Bowel Cancer Risk -- Menopausein Italy: Epidemilogical Studies and Medical Perception -- Aims, Methods, and Results of the Progetto Menopausa Italia -- Frequency of Cardiovascular Risks Factor in Women Attending Menopause Clinics: Findings from the ICARUS Data Base -- Determinants of Age at Menopause and Symptomatological Profile in Italian Women Attending Menopause Clinics in Italy -- Osteoporosis Risk Profile for Peri- and Postmenopausal Women Attending Menopause Clinics in Italy -- Menopause: What Is the Role of the General Practitioner? -- Bioethics, Menopause, and Aging: A View from the Italian Menopause Society.
|
| 650 |
# |
0 |
|a Medicine.
|
| 650 |
# |
0 |
|a Pharmacology.
|
| 650 |
# |
0 |
|a Public health.
|
| 650 |
# |
0 |
|a Cardiology.
|
| 650 |
# |
0 |
|a Epidemiology.
|
| 650 |
# |
0 |
|a Biochemistry.
|
| 650 |
1 |
4 |
|a Medicine & Public Health.
|
| 650 |
2 |
4 |
|a Cardiology.
|
| 650 |
2 |
4 |
|a Biochemistry, general.
|
| 650 |
2 |
4 |
|a Epidemiology.
|
| 650 |
2 |
4 |
|a Public Health.
|
| 650 |
2 |
4 |
|a Pharmacology/Toxicology.
|
| 710 |
2 |
# |
|a SpringerLink (Online service)
|
| 773 |
0 |
# |
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9780792359067
|
| 830 |
# |
0 |
|a Medical Science Symposia Series, Risk Reduction Strategies Ớ Improved Quality of Health ;
|v 13
|
| 856 |
4 |
0 |
|u https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-0-585-37973-9
|z View fulltext via EzAccess
|
| 912 |
# |
# |
|a ZDB-2-SME
|
| 912 |
# |
# |
|a ZDB-2-BAE
|
| 950 |
# |
# |
|a Medicine (Springer-11650)
|